Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,937Revenue $M2,173Net Margin (%)16.9Z-Score6.6
Enterprise Value $M9,083EPS $2.1Operating Margin %20.4F-Score8
P/E(ttm))23.3Cash Flow Per Share $0Pre-tax Margin (%)21.2Higher ROA y-yY
Price/Book5.710-y EBITDA Growth Rate %32.8Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %46.8Current Ratio2.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %34.1ROA % (ttm)17.7Higher Current Ratio y-yY
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)27.5Less Shares Outstanding y-yY
Payout Ratio %12.0Shares Outstanding M170ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

RDY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

    Quarterly/Annual Reports about RDY:

      News about RDY:

      Articles On GuruFocus.com
      Should You Buy Actavis? Mar 18 2014 
      Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
      5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
      Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
      Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

      More From Our Partners
      Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog Sep 25 2014 - ZACKS

      More From Other Websites
      Today's Market Thorns, Roses, and All Time Highs... Plus an Extra... Sep 25 2014
      Dr. Reddy's (RDY) Generic Xopenex Launched in the US Sep 25 2014
      Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP Sep 24 2014
      Dr. Reddy’s Announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP Sep 24 2014
      Should India Be On Investors' Radars? Sep 22 2014
      India Must Fix Its Drug Quality Problem Sep 17 2014
      India: Stock Picks As States Reform Aug 27 2014
      Tata Motors, Icici Bank Ride A Strong Week In India Aug 22 2014
      3 Stocks Dragging The Health Care Sector Downward Aug 11 2014
      Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y Aug 01 2014
      Impax Shares Plunge Post FDA Inspection of Taiwan Facility Jul 31 2014
      Dr. Reddy’s Q1 FY15 Financial Results Jul 30 2014
      Dr. Reddy’s Q1 FY15 Financial Results Jul 30 2014
      Who Benefits From India's New Budget Jul 28 2014
      Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher Jul 24 2014
      Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014 Jul 23 2014
      Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014 Jul 23 2014
      Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% Jul 16 2014
      Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% Jul 15 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK